Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism

European Journal of Internal Medicine

Volumn 21, Issue 4, 2010, Pages 289-292

  Beckers, M M J ^a   Ruven, H J T ^a   Haas, F J L M ^a   Doevendans, P A ^b   Ten Cate, H ^c   Prins, M H ^d   Biesma, D H ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Gene polymorphisms; Inflammation; Venous thromboembolism; VTE

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VENOUS THROMBOEMBOLISM; ADOLESCENT; AGED; CONFIDENCE INTERVAL; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HETEROZYGOTE; MIDDLE AGED; RISK; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-1ALPHA; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

IL1A PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6;

EID: 77955336836     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.04.001     Document Type: Article

References (33)

1. T. van der Poll, M. Levi, C.E. Hack, H. ten Cate, and S.J. van Deventer Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees J Exp Med 179 1994 1253 1259
2. P.H. Reitsma, and F.R. Rosendaal Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study J Thromb Haemost 2 2004 619 622
3. B.E. van Aken, P.H. Reitsma, and F.R. Rosendaal Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis Br J Haematol 116 2002 173 177
4. B.E. van Aken, M. den Heijer, G.M. Bos, S.J. van Deventer, and P.H. Reitsma Recurrent venous thrombosis and markers of inflammation Thromb Haemost 83 2000 536 539
5. T. van der Poll, E. de Jonge, and M. Levi Regulatory role in disseminated intravascular coagulation Semin Thromb Hemost 27 2001 639 651
6. S. Trompet, D. Pons, A.J. De Craen, P. Slagboom, J. Shepherd, and G.J. Blauw Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study Ann N Y Acad Sci 1100 2007 189 198
7. J. Wagner, W.E. Kaminski, C. Aslanidis, D. Moder, K.A. Hiller, and M. Christgau Prevalence of OPG and IL-1 gene polymorphisms in chronic periodontitis J Clin Periodontol 34 2007 823 827
8. S. Bagnoli, E. Cellini, A. Tedde, B. Nacmias, S. Piacentini, and V. Bessi Association of IL10 promoter polymorphism in Italian Alzheimer's disease Neurosci Lett 418 2007 262 265
9. L.F. Barcellos, A.B. Begovich, R.L. Reynolds, S.J. Caillier, D. Brassat, and S. Schmidt Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis Ann Neurol 55 2004 793 800
10. P.A. Kyrle, E. Minar, C. Bialonczyk, M. Hirschl, A. Weltermann, and S. Eichinger The risk of recurrent venous thromboembolism in men and women N Engl J Med. 350 2004 2558 2563
11. S. McRae, H. Tran, S. Schulman, J. Ginsberg, and C. Kearon Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis Lancet 368 2006 371 378
12. A.W. Tsai, M. Cushman, W.D. Rosamond, S.R. Heckbert, J.F. Polak, and A.R. Folsom Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology Arch Intern Med 162 2002 1182 1189 (Pubitemid 34522408)
13. C. Gangireddy, J.R. Rectenwald, G.R. Upchurch, T.W. Wakefield, S. Khuri, and W.G. Henderson Risk factors and clinical impact of postoperative symptomatic venous thromboembolism J Vasc Surg 45 2007 335 342
14. C.R. Keenan, and R.H. White The effects of race/ethnicity and sex on the risk of venous thromboembolism Curr Opin Pulm Med 13 2007 377 383
15. L.T. van Eijk, M.J. Dorresteijn, P. Smits, J.G. van der Hoeven, M.G. Netea, and P. Pickkers Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers Crit Care Med 35 2007 1464 1469
16. M.W. Wichmann, D. Inthorn, H.J. Andress, and F.W. Schildberg Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome Intensive Care Med 26 2000 167 172
17. D. Fishman, G. Faulds, R. Jeffery, V. Mohamed-Ali, J.S. Yudkin, and S. Humphries The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1998 1369 1376
18. M. Bennermo, C. Held, S. Stemme, C.G. Ericsson, A. Silveira, and F. Green Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem 50 2004 2136 2140
19. R. Dominici, M. Cattaneo, G. Malferrari, D. Archi, C. Mariani, and L.M. Grimaldi Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha Immunogenetics 54 2002 82 86
20. M. Heesen, B. Bloemeke, N. Heussen, and D. Kunz Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokines Crit Care Med 30 2002 664 669
21. E.A. Lynch, C.A. Dinarello, and J.G. Cannon Gender differences in IL-1α, IL1-β and IL-1 receptor antagonist secretion from mononuclear cells and urinary secretion J Immunol 153 1994 300 306
22. P. Prandoni Link between arterial and venous disease J Internal Medicine 262 2007 341 350
23. C.Q. Zhang, H. Huang, Z. Zhao, X.Z. Tang, B. Wang, and F. He Gene expression profile related to inflammation in rat model of traumatic deep vein thrombosis Chin J Traumatol 10 2007 206 212
24. J. Orbe, C. Chordá, R. Montes, and J.A. Páramo Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha Haematologica 84 1999 306 311
25. J.W. ten Cate, T. van der Poll, M. Levi, H. ten Cate, and S.J. van Deventer Cytokines: triggers of clinical thrombotic disease Thromb Haemost 78 1997 415 419
26. L.T. Osnes, A.B. Westvik, G.B. Joø, C. Okkenhaug, and P. Kierulf Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13 Cytokine 8 1996 822 827
27. S.T. Smiley, S.N. Boyer, M.J. Heeb, J.H. Griffin, and M.J. Grusby Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity Proc Natl Acad Sci U S A 94 1997 11484 11489
28. K. Silander, M. Alanne, K. Kristiansson, O. Saarela, S. Ripatti, K. Auro, J.S. Karvanen, M. Niemelä, P. Ellonen, E. Vartiainen, P. Jousilahti, J. Saarela, K. Kuulasmaa, A. Evans, M. Perola, V. Salomaa, and L. Peltonen Gender differences in genetic risk profiles for cardiovascular disease PLoS ONE 3 10 2008 e3615
29. D.J. Brull, H.E. Montgomery, J. Sanders, S. Dhamrait, L. Luong, and A. Rumley Interleukin-6 gene - 174 g > c and - 572 g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery Arterioscler Thromb Vasc Biol 21 2001 1458 1463
30. R. Vormittag, K. Hsieh, A. Kaider, E. Minar, C. Bialonczyk, and M. Hirschl Interleukin-6 and interleukin-6 promoter polymorphism (- 174) G > C in patients with spontaneous venous thromboembolism Thromb Haemost 95 2006 802 806
31. M. Zangari, F. Saghafifar, P. Mehta, B. Barlogie, L. Fink, and G. Tricot The blood coagulation mechanism in multiple myeloma Semin Thromb Hemost 29 2003 275 282
32. P.H. Reitsma, and F.R. Rosendaal Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study J Thromb Haemost 2 2004 619 622
33. S.C. Christiansen, I.A. Naess, S.C. Cannegieter, J. Hammerstrøm, F.R. Rosendaal, and P.H. Reitsma Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study PLoS Med 3 2006 e334